-transparent.png){kind=logo}
Results of treatment in 72 children with a relapse of acute lymphoblastic leukaemia were analysed. A second remission was induced in 57 children (79%). Remission rates were significantly higher in males, and in patients with white cell counts less than 30 X 10(9)/L. The median duration of the second remission was only four months, and the median duration of survival from the time of relapse was nine months. The median duration of survival from the time of diagnosis was 27 months. Among children who suffered a relapse was a small group who had prolonged survival and prolonged second remissions. It is uncertain whether some of these may have a chance of "cure".
Related Publications
H Ekert, and
W M Ellis, and
K D Waters, and
R N Matthews
December 2005,
British journal of haematology,
H Ekert, and
W M Ellis, and
K D Waters, and
R N Matthews
April 2003,
British journal of haematology,
H Ekert, and
W M Ellis, and
K D Waters, and
R N Matthews
April 1983,
British medical journal (Clinical research ed.),
H Ekert, and
W M Ellis, and
K D Waters, and
R N Matthews
September 2013,
British journal of haematology,
H Ekert, and
W M Ellis, and
K D Waters, and
R N Matthews
July 1978,
British medical journal,
H Ekert, and
W M Ellis, and
K D Waters, and
R N Matthews
April 1990,
The Medical journal of Australia,
H Ekert, and
W M Ellis, and
K D Waters, and
R N Matthews
September 1984,
Scandinavian journal of haematology,
H Ekert, and
W M Ellis, and
K D Waters, and
R N Matthews
December 1979,
British journal of cancer,
H Ekert, and
W M Ellis, and
K D Waters, and
R N Matthews
August 1978,
British medical journal,
H Ekert, and
W M Ellis, and
K D Waters, and
R N Matthews
August 2003,
Lancet (London, England),
